Patient 2, who did not develop a positive skin reaction after chemotherapy with IFN, interleukin-2 and 5-fluorouracil, partially responded to vaccination therapy after a delay. The study ended in ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Dendritic cell therapy has emerged as a promising alternative for treating various forms of cancer, particularly in ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

UVA Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies ...

Researchers Shed Light on How to Predict Which Skin Cancer Patients ... Increase Treatment-Resistant Melanoma Sep. 6, 2024 — Age-related changes in the fibroblasts, cells that create the skin's ...

PHILADELPHIA- Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the therapy itself caused any type of secondary cancer in the modified ...

1Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.

The National Health Service (NHS) has approved a groundbreaking £1.65 million treatment for sickle cell disease in England, offering patients a promising 96.6% cure rate. The new therapy, hailed as a ...